IL46802A - Method for preparing stable betalactam-type-antibiotic susceptibility test discs - Google Patents
Method for preparing stable betalactam-type-antibiotic susceptibility test discsInfo
- Publication number
- IL46802A IL46802A IL46802A IL4680275A IL46802A IL 46802 A IL46802 A IL 46802A IL 46802 A IL46802 A IL 46802A IL 4680275 A IL4680275 A IL 4680275A IL 46802 A IL46802 A IL 46802A
- Authority
- IL
- Israel
- Prior art keywords
- antibiotic
- type
- paper
- lactam
- discs
- Prior art date
Links
- 238000009635 antibiotic susceptibility testing Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 32
- 239000006185 dispersion Substances 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 15
- 238000012360 testing method Methods 0.000 claims description 43
- 230000003115 biocidal effect Effects 0.000 claims description 28
- 229960000603 cefalotin Drugs 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 230000002745 absorbent Effects 0.000 claims description 8
- 239000002250 absorbent Substances 0.000 claims description 8
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 7
- 238000001704 evaporation Methods 0.000 claims description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 4
- 229910052753 mercury Inorganic materials 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 229950004030 cefaloglycin Drugs 0.000 claims description 3
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 claims description 3
- 229960003866 cefaloridine Drugs 0.000 claims description 3
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 claims description 3
- 229940106164 cephalexin Drugs 0.000 claims description 3
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims description 3
- -1 defaman-do e Chemical compound 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 229940056360 penicillin g Drugs 0.000 claims description 3
- 229930195708 Penicillin V Natural products 0.000 claims description 2
- OLVCFLKTBJRLHI-AXAPSJFSSA-N cefamandole Chemical compound CN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)[C@H](O)C=3C=CC=CC=3)[C@H]2SC1 OLVCFLKTBJRLHI-AXAPSJFSSA-N 0.000 claims description 2
- 229960003012 cefamandole Drugs 0.000 claims description 2
- 229960001139 cefazolin Drugs 0.000 claims description 2
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 claims description 2
- 229960002682 cefoxitin Drugs 0.000 claims description 2
- 229940056367 penicillin v Drugs 0.000 claims description 2
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- XIURVHNZVLADCM-IUODEOHRSA-N cefalotin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CC1=CC=CS1 XIURVHNZVLADCM-IUODEOHRSA-N 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000013078 crystal Substances 0.000 abstract description 10
- 238000000151 deposition Methods 0.000 abstract description 4
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 24
- 239000003242 anti bacterial agent Substances 0.000 description 13
- 229940088710 antibiotic agent Drugs 0.000 description 13
- 238000003860 storage Methods 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 229930186147 Cephalosporin Natural products 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000012009 microbiological test Methods 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 150000002960 penicillins Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000010960 commercial process Methods 0.000 description 2
- 238000010981 drying operation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- NWWJFMCCTZLKNT-UHFFFAOYSA-N 3,4-dihydro-2h-thiazine Chemical group C1CC=CSN1 NWWJFMCCTZLKNT-UHFFFAOYSA-N 0.000 description 1
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 1
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N Cephalosporin C Natural products S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012984 antibiotic solution Substances 0.000 description 1
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- HOKIDJSKDBPKTQ-GLXFQSAKSA-M cephalosporin C(1-) Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H]([NH3+])C([O-])=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-M 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000010898 paper trimming Substances 0.000 description 1
- 238000010951 particle size reduction Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Cephalosporin Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/461,465 US3937655A (en) | 1974-04-16 | 1974-04-16 | Method for preparing stable β-lactam-type-antibiotic susceptibility test discs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL46802A0 IL46802A0 (en) | 1975-05-22 |
| IL46802A true IL46802A (en) | 1977-10-31 |
Family
ID=23832669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL46802A IL46802A (en) | 1974-04-16 | 1975-03-12 | Method for preparing stable betalactam-type-antibiotic susceptibility test discs |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US3937655A (pl) |
| JP (1) | JPS5820600B2 (pl) |
| AR (1) | AR204134A1 (pl) |
| AT (1) | AT342762B (pl) |
| BE (1) | BE827892A (pl) |
| BG (1) | BG26405A3 (pl) |
| BR (1) | BR7502295A (pl) |
| CA (1) | CA1038270A (pl) |
| CH (1) | CH609376A5 (pl) |
| CS (1) | CS199585B2 (pl) |
| DD (1) | DD118725A5 (pl) |
| DE (1) | DE2513416C2 (pl) |
| DK (1) | DK140377B (pl) |
| ES (1) | ES436645A1 (pl) |
| FR (1) | FR2268076B1 (pl) |
| GB (1) | GB1500994A (pl) |
| HU (1) | HU170560B (pl) |
| IE (1) | IE40767B1 (pl) |
| IL (1) | IL46802A (pl) |
| IT (1) | IT1037379B (pl) |
| NL (1) | NL183303C (pl) |
| PH (1) | PH10750A (pl) |
| PL (1) | PL98700B1 (pl) |
| RO (1) | RO67254A (pl) |
| SE (1) | SE421804B (pl) |
| SU (1) | SU579903A3 (pl) |
| ZA (1) | ZA751443B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4153512A (en) * | 1976-04-07 | 1979-05-08 | Fisher Scientific Company | Storage stable antibiotic susceptibility test kit and method of testing |
| GB2107307B (en) * | 1981-07-25 | 1986-02-26 | Beecham Group Plc | B-lactum antibacterial agents |
| JPS58179499A (ja) * | 1982-04-13 | 1983-10-20 | Wako Pure Chem Ind Ltd | 細菌感受性試験ディスク |
| GB2128737B (en) * | 1982-10-07 | 1986-02-05 | Beecham Group Plc | Antibiotic susceptibility test material |
| US5026638A (en) * | 1988-07-27 | 1991-06-25 | George Saperstein | Antibiotic sensitivity test for pathogenic organisms present in mastitic milk |
| US7067500B2 (en) | 1997-05-02 | 2006-06-27 | Integrated Research Technology, Llc | Betaines as adjuvants to susceptibility testing and antimicrobial therapy |
| AU7365298A (en) * | 1997-05-02 | 1998-11-27 | Integrated Research Technology, Llc | Betaines as adjudvants to susceptibility testing and antimicrobial thera py |
| FR3016169B1 (fr) | 2014-01-09 | 2017-12-15 | Biomerieux Sa | Procede de detection, identification et enumeration de micro-organismes dans un support poreux impregne a sec par un milieu reactionnel deshydrate |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE24557E (en) * | 1954-03-01 | 1958-10-28 | Means for assessing the effect of var- | |
| US3138544A (en) * | 1961-05-03 | 1964-06-23 | British Drug Houses Canada Ltd | Microbial sensitivity testing device |
| US3713985A (en) * | 1970-10-19 | 1973-01-30 | Kantor F | Device and method for testing potency of biological control reagents |
-
1974
- 1974-04-16 US US05/461,465 patent/US3937655A/en not_active Expired - Lifetime
-
1975
- 1975-01-01 AR AR258336A patent/AR204134A1/es active
- 1975-03-07 CA CA221,593A patent/CA1038270A/en not_active Expired
- 1975-03-10 IE IE509/75A patent/IE40767B1/xx unknown
- 1975-03-10 ZA ZA00751443A patent/ZA751443B/xx unknown
- 1975-03-12 IL IL46802A patent/IL46802A/en unknown
- 1975-03-14 PH PH16917A patent/PH10750A/en unknown
- 1975-03-26 DE DE2513416A patent/DE2513416C2/de not_active Expired
- 1975-04-02 JP JP50040788A patent/JPS5820600B2/ja not_active Expired
- 1975-04-08 SE SE7504012A patent/SE421804B/xx not_active IP Right Cessation
- 1975-04-09 BG BG029595A patent/BG26405A3/xx unknown
- 1975-04-11 FR FR7511394A patent/FR2268076B1/fr not_active Expired
- 1975-04-11 DD DD185392A patent/DD118725A5/xx unknown
- 1975-04-12 PL PL1975179584A patent/PL98700B1/pl unknown
- 1975-04-14 GB GB15161/75A patent/GB1500994A/en not_active Expired
- 1975-04-14 BE BE1006589A patent/BE827892A/xx not_active IP Right Cessation
- 1975-04-15 HU HUEI613A patent/HU170560B/hu unknown
- 1975-04-15 CS CS752605A patent/CS199585B2/cs unknown
- 1975-04-15 DK DK161875AA patent/DK140377B/da not_active IP Right Cessation
- 1975-04-15 IT IT22367/75A patent/IT1037379B/it active
- 1975-04-15 BR BR2921/75A patent/BR7502295A/pt unknown
- 1975-04-15 NL NLAANVRAGE7504434,A patent/NL183303C/xx active Search and Examination
- 1975-04-16 CH CH487575A patent/CH609376A5/xx not_active IP Right Cessation
- 1975-04-16 ES ES436645A patent/ES436645A1/es not_active Expired
- 1975-04-16 AT AT288975A patent/AT342762B/de not_active IP Right Cessation
- 1975-04-16 RO RO7582004A patent/RO67254A/ro unknown
- 1975-10-31 SU SU7502191052A patent/SU579903A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mates et al. | Membrane potential and gentamicin uptake in Staphylococcus aureus. | |
| Isquith et al. | Surface-bonded antimicrobial activity of an organosilicon quaternary ammonium chloride | |
| AU678609B2 (en) | A novel antifungal composition | |
| US3937655A (en) | Method for preparing stable β-lactam-type-antibiotic susceptibility test discs | |
| Archibald et al. | Bacteriophage SP50 as a marker for cell wall growth in Bacillus subtilis | |
| Wetzel et al. | Cytochemical localization of certain phosphatases in Escherichia coli | |
| Hall et al. | Antitumor agents XXX: Evaluation of α‐methylene‐γ‐lactone‐containing agents for inhibition of tumor growth, respiration, and nucleic acid synthesis | |
| Thompson et al. | Na+ and K+ gradients and α-aminoisobutyric acid transport in a marine pseudomonad | |
| Dimmick et al. | Evidence for more than one division of bacteria within airborne particles | |
| Black et al. | PERMEABILITY OF BACTERIAL SPORES I: Characterization of Glucose Uptake | |
| Basker et al. | Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of Pseudomonas aeruginosa and Klebsiella aerogenes | |
| Cox et al. | Aerosol survival of Pasteurella tularensis and the influence of relative humidity | |
| Ehrlich et al. | Effects of atmospheric humidity and temperature on the survival of airborne Flavobacterium | |
| Record et al. | Some Factors influencing the Survival of Bucterium coli on Freeze-drying | |
| KR790001655B1 (ko) | β-락탐 항생물질의 감수성 시험용 디스크의 제조방법 | |
| Alwen et al. | A medium to suppress the swarming of Proteus species | |
| Cox et al. | Viability and electron microscope studies of phages T3 and T7 subjected to freeze-drying, freeze-thawing and aerosolization | |
| Davis et al. | RELATIVE HUMIDITY AND THE KILLING OF BACTERIA: I. Observations on Escherichia coli and Micrococcus lysodeikticus | |
| Commager et al. | Mechanism of action of phenolic disinfectants VI: effects on glucose and succinate metabolism of Escherichia coli | |
| Barug et al. | Effect of the imidazole derivative lombazole on the ultrastructure of Staphylococcus epidermidis and Candida albicans | |
| Morris et al. | The quantitative assay of mono-dispersed aerosols of bacteria and bacteriophage by electrostatic precipitation | |
| Thabaut et al. | Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis | |
| JPS58179499A (ja) | 細菌感受性試験ディスク | |
| JP3710153B2 (ja) | 水溶液中でカラム材料を保存するための組合せ物及び水性カラム材料 | |
| Dadd et al. | The influence of water on the resistance of spores to inactivation by gaseous ethylene oxide |